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CLIMATE CHANGE AND COMMUNICABLE DISEASES
Tracking infectious diseases in a warming world
Using infectious diseases sensitive to climate as indicators of climate change helps stimulate and
inform public health responses, write Kris A Murray and colleagues
Kris A Murray, 1, 2, 3, 4 Luis E Escobar, 5 Rachel Lowe, 4, 6, 7 Joacim Rocklöv, 8 Jan C Semenza, 9 Nick Watts10
In one of the first articles published by The BMJ on
climate change, Haines in 1991 wrote: “Eight of the
hottest 10 years this century have occurred since
1980.”1 Noting the influence of temperature on the
life cycles of several vectors, hosts, and pathogens,
Haines went on to question the implications of
predicted climate change for many infectious
diseases. It is discomforting that today, three decades
later, circumstances have hardly changed, and that
early forecasts have begun to ring true.2 3 Eight of the
10 hottest years on record have now occurred since
20104; associations between climate change and the
burden, transmission, or distribution of many
infectious diseases (principally causedbyprotozoan,
helminth, vectorborne, foodborne, soilborne, and
waterborne pathogens) are increasingly being
reported5; theEuropeanCentre forDiseasePrevention
and Control (ECDC) now ranks climate among the
most frequently implicated “drivers” of infectious
disease threats6; and The World Health Organization
now recognises climate change as one of the major
health challenges of the 21st century.7
In such a rapidly changing world, how can
researchers, health professionals, and policy makers
keep track of the risks and intervene accordingly?
How can policy options be evaluated, particularly
when aiming to achieve globally agreed sustainable
development, environmental (including the Paris
Agreement), and health management targets?8 9
One emerging strategy is the use of climate change
“indicators,” which aim to keep track of historical
and future predicted trends in key impact areas
related to climate change. Such indicators have taken
on a range of functions, including quantifying and
characterizing exposure, vulnerability, and risk for
bothpopulations andhealth systems, identifying and
tracking key impacts on population health, and
evaluating changes in adaptive capacity and
resilience.10 Indicator initiatives explicitly aim to go
beyond the fractured andoften inconsistent evidence
base presented in the primary scientific literature to
bring together or generate relevant information in
some generally consistent fashion. They also tend to
focus more specifically on the analysis of trends
through time, often with an emphasis on accessible
yet powerful data sharing and visualizations to
stimulate action across sectors and track progress
towards some predefined targets. Here we illustrate
how “climate-sensitive infectious diseases” (CSIDs)
are being used as climate change indicators to help
stimulate and inform public health responses to
climate change.
Climate change and health indicators
An example of a benchmark for the quantification
and comparison of varying health outcomes is the
Global Burden of Disease (GBD) programme.11 This
quantifies death and loss of health and wellbeing
from hundreds of diseases and their risk factors, and
is used to guide health surveillance and improve
global health management policies. However,
although the GBD programme estimates the global
burden of several CSIDs, it does not capture some
important but difficult to define health impacts,
including from health inequalities or climate
change.12
Several climate change indicator initiatives exist that
seek to partially fill this gap. Indicator initiatives
specifically targeting climate change and health are
relatively recent but have been advocated for widely,
with key efforts including examples from learned
societies,12 health authorities (eg, the US Centers for
Disease Control and Prevention (CDC)13), other
government agencies (eg, the US Environmental
Protection Agency,14 the European Environment
Agency, and the forthcoming proposal for an EU
observatory for climate change and health and the
EU Adaptation Strategy planned for 202115), funders
(eg, Wellcome Trust16), and academic consortiums
(eg, the Inter-Sectoral ImpactModel Intercomparison
Project17 and the Lancet Countdown on Health and
Climate Change18). Such indicator initiatives range
in scale from local to global.
Where numerous indicator initiatives have tackled
some of the more direct impacts of climate change
on health or those for which greater volume and
quality of data exist (eg, heat-related mortality), few
indicators exist for more complex, indirect impact
areas such as infectious diseases. For example, the
CDCTrackingNetwork currently reports on flood and
heat vulnerability trendsbutnot infectiousdiseases.13
Global trends in climate sensitive infectious
diseases
Current CSID indicators focus primarily on the
climatic suitability or population vulnerability
components of disease transmission risk, as opposed
to case or burden data.
To illustrate, we briefly highlight some of our work
as part of the Lancet Countdown on Health and
Climate Change,19 for which we have developed
indicators to: (1) assess spatial and temporal trends
in the environmental suitability for CSID transmission
(for dengue,malaria, andpathogenicVibriobacteria);
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and (2) evaluate the changing basis of population vulnerability to
arboviruses (ie, factoring innational characteristics that define their
propensity to be adversely affected by infectious disease threats,
such as public health measures).
Briefly, indicator analyses for dengue, malaria, and pathogenic
Vibrio bacteria show increases in the environmental suitability for
disease transmission over past decades. For example, 2017 was the
second most suitable year on record for the transmission of dengue
virus, with average increases of 7.2% and 9.8% in vectorial capacity
observed in the past five years compared with a 1950s baseline for
the key vectors Aedes aegypti and A albopictus, respectively (fig 1).
Despite these increases, country level vulnerability to dengue
outbreaks (ie, exposure to mosquitoes after controlling for the
presence of disease-relevant public healthmeasures) has decreased
globally by 31% since 2010, although some regions remain more
vulnerable than others and progress has reversed in these regions
in recent years (fig 2). The number of suitable months per year for
the transmission ofmalaria (Plasmodium falciparum) in theAfrican
highlands has increased by 29.9% in the past five years compared
to a 1950s baseline. By contrast, other regions do not show an
increasing trend for malaria, potentially due to some areas (eg,
lowlands) becoming toowarmor experiencing shifts away from the
combinations of temperature, rainfall, and humidity that enhance
transmission (fig 3). For waterborne diseases caused by pathogenic
Vibrio bacteria, similarly strong increases in the percentage of
coastal area suitable for transmission are observed at northern
latitudes (40-70° N) (fig 4 top), in the Baltic Sea (fig 4 middle) and
along the north east coast of the United States (fig 4 bottom). The
number of days per year suitable for Vibrio in the Baltic reached
107 in 2018, double the early 1980s baseline (fig 4 middle).
Fig 1 | Mathematical models of dengue vectorial capacity for A aegypti and A albopictus mosquitoes reveal temporal changes in the potential for dengue transmission due
to a warming climate since 1950.
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Fig 2 | Despite the increases in environmental suitability for dengue shown in fig 1, improved public health measures have on average lowered vulnerability to dengue
outbreaks across most regions since 2010, although some recent reversals in this trend are observed in the more vulnerable regions.
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Fig 3 | The number of suitable months a year for malaria transmission during the period 1950-2017, as determined by combinations of temperature, rainfall, and humidity,
are increasing predominantly in the African highlands (ie, elevation >=1500 m). No change or subtle declines in environmental suitability are observed in other regions.
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Fig 4 | Change in environmental suitability for pathogenic Vibrio outbreaks as determined by observed correlations with sea surface temperatures and ocean salinity. This
model suggests that suitability is increasing predominantly in the northern hemisphere (top; northern latitudes=40-70°N; tropical latitudes=25°S-40°N; southern
latitudes=25-40°S). More detailed analysis by regions shows, for example, that the Baltic Sea (middle) and the United States north east coast (bottom) are also increasingly
suitable for Vibrio outbreaks due to climate change. For details on methodology and expanded interpretations, see the Lancet Countdown on Health and Climate Change19).
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Each CSID indicator aims to capture environmental suitability of
disease transmissionbymathematically linkingpreferred conditions
for transmission with climate input data. This allows the long term
assessment of how environmental suitability for disease
transmission has changed in recent decades, providing an initial
step towards the attribution of disease risk to anthropogenic climate
change.
Attribution of the underlying climate trends to human greenhouse
gas emissions is highly robust20; however, it remains difficult to
isolate the specific fraction of observed cases of each disease to
climate change at large spatial scales given the range of other
environmental and socioeconomic covariates at play. These include
health inequality (ie, potential for the population to be harmed by
a disease due to differential access to healthcare), land use,
biodiversity, urbanization, travel and tourism, and global trade.
Many of these factors are themselves influenced by climate change
and exhibit strong spatial and temporal heterogeneities, illustrating
the depth of the complexity of resolving realized climate change
impacts on CSID burdens at continental or global scales.21
In addition, this set of indicators comprises several different
methods (eg, threshold based, mechanistic, correlative models),
datasets (eg, baseline gridded climate data),metrics (eg, percentage
change versus raw change in suitability, indices of environmental
suitability versus specific metrics such as vectorial capacity), and
temporal windows (eg, baseline period, length of time series).
Different methods reflect the project’s participatory, in kind,
reformulationapproach.However, amore systematic effort isneeded
to prioritize formally and objectively which diseases should be
tracked, to develop standardized methodologies across diseases
when possible, and to link outcomes to trends in other sectors, such
as food security and access to healthcare, for a range of downstream
uses.
Data sharing, use, and public health application
Awide range of public health stakeholders, ranging from theGlobal
Climate and Health Alliance to the International Council of Nurses
and the Royal College of Physicians, are increasingly engaged in
climate change as a health issue. These professionals depend on
both the generation of new medical evidence to drive this agenda
forward, and thepresentationof evidence in away that they readily
understand and can amplify to help drive both mitigation (eg,
actions to reduce greenhouse gas emissions of healthcare
infrastructure and services) and adaptation strategies (eg,
identifying CSID hotspots, designing surveillance networks, early
warning systems) to prepare for the changing risks from CSIDs to
reduce their impacts.
Improving access to robust climate change risk assessments for
health exposures and outcomes allows users to explore and
appreciate the spatial and temporal heterogeneities in
climate-related health risks relevant to local and coordinated
management. For instance, the Lancet Countdown CSID indicators
can be explored through an online visualization platform18 to
highlight geographic areas that may be experiencing increases or
decreases in disease risk, identify locations that require more
research for amore accurateunderstandingof CSID risk, or highlight
humanpopulationswhere inequity gaps requireurgent intervention
to reduce their vulnerability to emerging climate change related
public health threats. Accessible data sharing platforms provide a
powerful avenue for users to visualize and interact with data, to
appreciate the current situation in the context of the longer term
trajectory, and to evaluate the growingmomentumof certain trends
through time and the often invisible build-up towards potential
health crises. They also highlight the potential downstream impacts
that greenhousegas emissions today couldhaveonhealthoutcomes
in the future.
Furthermore, given the scale and pace of the challenge that climate
change presents, CSID indicator outputs must be paired with
dedicated efforts to ensure they are translated into languages and
formats that a wide range of audiences understand, ideally
co-designed with policy makers and potential users. The
developmentof anextensivenetworkofpolicy and researchpartners
is necessary to link key health bodies (eg, World Health Assembly,
the World Health Summit, and the United Nations Framework
ConventiononClimate Change’s decisionmakingbody)withhealth
scientists and practitioners. Similarly, scientific literature must be
paired with policy briefings, engaging narrative, and creative
outputs if it is to engage across disciplines and help to draw out the
local media and policy stories that may otherwise be hidden (for
examples, see Lancet Countdown22).
Collaborations and investment
Climate change is increasingly being recognized as a public health
emergency.23 Health risks and impactswill continue to growunless
the global community raises its collective ambition tomeet the Paris
Agreement, which aims to keep the world below 2°C warming, and
preferably below 1.5°C.24 This goal, however, requires
evidence-based, transformative, and immediate action to curb
greenhouse gas emissions.
While monitoring changes in climate under the Paris Agreement is
crucial, equally important is themonitoring of potential health risks
related to climate change. Better data for tracking infectious disease
in a warming world requires a robust evidence base, recogniing
that the challengesposedby climate change tohealth are substantial
in size, complexity, and scope.
Initiatives to track the impacts of climate change (including
increased variability in extremeevents) and the effects of adaptation
efforts on CSIDs have recently emerged to meet this challenge. The
development and implementation of indicators calls for
international, multi-disciplinary research collaborations dedicated
to monitoring, analysing, anticipating, and communicating the
links between climate change and health across the world.
Greater investment is required to help such initiatives realize their
full potential to accurately identify the contribution of climatic
drivers of infectious disease risk across space and time. In turn,
identification and dissemination of climate-disease trends will
signpost researchers, policy makers, health professionals, and the
general public towards more informed, pre-emptive mitigation and
adaptation actions to guidepublic health practice to anaccelerated
response to what has been termed by WHO as the “greatest global
health threat of the 21st century.”7
Key recommendations
• Development, standardization, and implementation of climate change
and health indicators requires multidisciplinary research
collaborations and major investment
• A systematic assessment of climate sensitive infectious diseases is
required to prioritize diseases for tracking
• Standardized methodologies across diseases are needed with
outcomes linked to trends in other sectors
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• Indicator outputs should be accessible and translated into languages
and formats for diverse audiences, co-designed with policy makers
and users
• Scientific reports should be paired with policy briefings, engaging
narrative, and creative outputs to maximize media coverage and policy
engagement
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